— Know what they know.
Not Investment Advice

RKDA NASDAQ

Arcadia Biosciences, Inc.
1W: +4.4% 1M: -48.1% 3M: -75.4% YTD: -92.6% 1Y: -96.1% 3Y: -95.0% 5Y: -99.8%
$0.16
+0.01 (+5.27%)
 
Weekly Expected Move ±14.6%
$0 $0 $0 $0 $0
NASDAQ · Basic Materials · Agricultural Inputs · Tech Score Strong Sell · Power 26 · $247261 mcap · 2M float · 123.13% daily turnover · Short 13% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -169.46.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$5M -3.7% ▼
5Y CAGR: -9.6%
Gross Profit
$2M -15.5% ▼
5Y CAGR: -9.1%
Operating Income
-$10M -174.0% ▼
Net Income
-$2M +66.8% ▲
EPS (Diluted)
$-1.71 +66.9% ▲
EBITDA
-$10M -31.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$7M$7M$4M$5M$5M
YoY Growth-15.6%+46.8%-46.5%-5.3%-3.7%
Cost of Revenue$9M$6M$2M$3M$3M
Gross Profit-$2M$1M$2M$2M$2M
Gross Margin-28.4%17.8%51.2%41.3%36.2%
R&D Expenses$4M$2M$64K$53K$9K
SG&A Expenses$23M$15M$8M$10M$7M
Operating Expenses$34M$15M$8M$6M$12M
Operating Income-$36M-$14M-$6M-$4M-$10M
Operating Margin-524.0%-188.8%-137.0%-72.3%-205.7%
Interest Expense$20K$0$0$0$0
Income Before Tax-$16M-$11M-$5M-$4M-$2M
Tax Expense$2K$14K$8K$8K$8K
Net Income-$15M-$15M-$14M-$7M-$2M
Net Margin-216.2%-207.3%-313.9%-139.5%-48.1%
EPS (Diluted)$-30.33$-26.05$-11.30$-5.16$-1.71
EBITDA-$28M-$15M-$6M-$7M-$10M
Shares Outstanding5320155993891M1M1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms